PREVENTION OF URSODEOXYCHOLATE HEPATOTOXICITY IN THE RABBIT BY CONJUGATION WITH N-METHYL AMINO-ACIDS

被引:16
作者
SCHMASSMANN, A
HOFMANN, AF
ANGELLOTTI, MA
TONNU, HT
SCHTEINGART, CD
CLERICI, C
ROSSI, SS
ROTHSCHILD, MA
COHEN, BI
STENGER, RJ
MOSBACH, EH
机构
[1] BETH ISRAEL MED CTR,DEPT SURG,LIPID LAB,10 NATHAN D PERLMAN PL,NEW YORK,NY 10003
[2] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[3] VET ADM MED CTR,DEPT NUCL MED,NEW YORK,NY 10010
[4] NASSAU CTY MED CTR,DEPT PATHOL,E MEADOW,NY 11554
关键词
D O I
10.1002/hep.1840110613
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The effect of dietary administration of four different amino acid (N‐acyl) conjugates of ursodeoxycholic acid on biliary bile acid composition, liver tests and hepatic morphology by light microscopy was examined in the rabbit. Each group of four to five rabbits received a chow diet supplemented with a single conjugate of ursodeoxycholic acid ursodeoxycholylglycine, ursodeoxycholyl‐sarcosine, ursodeoxycholyltaurine or ursodeoxycholyl‐N‐methyltaurine for 3 wks at a dose of 50 mg/kg/day; a control group received chow alone. After 3 wks of feeding, animals receiving ursodeoxycholyl‐glycine or ursodeoxycholyl‐taurine had hepatotoxicity associated with abnormal liver tests. Lithocholic acid made up 11% ± 2.7% of biliary bile acids in the ursodeoxycholyl‐glycine and 10% ± 2.2% in the ursodeoxycholyl‐taurine group. In contrast, animals receiving ursodeoxycholyl‐sarcosine or ursodeoxycholyl‐N‐methyltaurine had neither hepatotoxicity nor abnormal liver tests and the proportion of lithocholic acid in biliary bile acids increased much less. Complementary studies showed that ursodeoxycholyl‐sarcosine and ursodeoxycholyl‐N‐methyltaurine were not biotransformed during hepatic transport and were resistant to deconjugation and dehydroxylation in the rabbit. These experiments indicate that the N‐methyl amino acid conjugates of ursodeoxycholic acid are nontoxic in the rabbit and resist deconjugation and dehydroxylation. Such resistance decreases formation of lithocholic acid in the colon, thus reducing its accumulation and consequent induction of hepatotoxicity.(HEPATOLOGY 1990;11:989‐996.). Copyright © 1990 American Association for the Study of Liver Diseases
引用
收藏
页码:989 / 996
页数:8
相关论文
共 46 条
[1]   LITHOCHOLATE METABOLISM DURING CHEMOTHERAPY FOR GALLSTONE DISSOLUTION .2. ABSORPTION AND SULFATION [J].
ALLAN, RN ;
THISTLE, JL ;
HOFMANN, AF .
GUT, 1976, 17 (06) :413-419
[2]   URSODEOXYCHOLIC ACID IN THE TREATMENT OF CHOLESTEROL CHOLELITHIASIS .1. [J].
BACHRACH, WH ;
HOFMANN, AF .
DIGESTIVE DISEASES AND SCIENCES, 1982, 27 (08) :737-761
[3]   URSODEOXYCHOLIC ACID IN THE TREATMENT OF CHOLESTEROL CHOLELITHIASIS .2. [J].
BACHRACH, WH ;
HOFMANN, AF .
DIGESTIVE DISEASES AND SCIENCES, 1982, 27 (09) :833-856
[4]  
BATTA AK, 1984, J BIOL CHEM, V259, P5035
[5]   THE EFFECT OF TAUROURSODEOXYCHOLIC ACID AND TAURINE SUPPLEMENTATION ON BILIARY BILE-ACID COMPOSITION [J].
BATTA, AK ;
SALEN, G ;
SHEFER, S ;
TINT, GS ;
DAYAL, B .
HEPATOLOGY, 1982, 2 (06) :811-816
[6]   LOCALIZATION OF BILE SALT ABSORPTION IN VIVO IN RABBIT [J].
BUCHWALD, H ;
GEBHARD, RL .
ANNALS OF SURGERY, 1968, 167 (02) :191-&
[7]   DIFFERING EFFECTS OF NOR-URSODEOXYCHOLIC OR URSODEOXYCHOLIC ACID ON HEPATIC HISTOLOGY AND BILE-ACID METABOLISM IN THE RABBIT [J].
COHEN, BI ;
HOFMANN, AF ;
MOSBACH, EH ;
STENGER, RJ ;
ROTHSCHILD, MA ;
HAGEY, LR ;
YOON, YB .
GASTROENTEROLOGY, 1986, 91 (01) :189-197
[8]  
COLEMAN JP, 1987, J BIOL CHEM, V262, P4701
[9]  
EINARSSON K, 1980, J LIPID RES, V21, P23
[10]   EFFECT OF CHOLIC ACID FEEDING ON BILE-ACID KINETICS AND NEUTRAL FECAL STEROID EXCRETION IN HYPERLIPOPROTEINEMIA (TYPES II AND IV) [J].
EINARSSON, K ;
HELLSTROM, K ;
KALLNER, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1974, 23 (09) :863-873